Le Lézard
Classified in: Health
Subject: PER

Safe Rx adds Sales and Marketing Executives Andy Cipra & Rick Meckstroth


GREENWOOD VILLAGE, Colo., Feb. 14, 2018 /PRNewswire/ -- Safe Rx LLC is announcing the appointment of Andy Cipra to the role of Chief Commercial Officer and Rick Meckstroth to Vice President of Business Development.  

www.safe-rx.com

Mr. Cipra & Mr. Meckstroth combined have over 60 years of sales, marketing and product development experience at large companies including 3M and Procter & Gamble while also driving growth in smaller, private companies and venture backed startups.

"These new additions to our senior team position us to manage significant growth as we roll out LPV dispensing to protect American communities and families from the risk of addiction," said Milton Cohen, President & CEO.

Mr. Cipra most recently served as Chief Commercial Officer for MedAvail Technologies and VP Marketing for DISH Network.  Prior to that he led billion dollar brands at P&G including Iams Pet food and Vicks NyQuil, DayQuil and VapoRub.  Andy is a classically trained marketer and proven business leader.

"We are at a critical national crossroads in fighting the opioid epidemic, and I look forward to helping create the new standard for safe prescription packaging and dispensing as part of the Safe Rx team.  The idea behind Safe Rx is simple and the impact we can have on saving lives is profound," said Mr. Cipra. 

Mr. Meckstroth is a senior sales and marketing executive with over 35 years of experience in personal health care and pharmaceuticals.  He spent 30 years with Procter & Gamble in a variety of leadership positions in both domestic and global business units.  He will be leading the expansion of the product to pharmacies and health systems.

Prescription drugs are the number one gateway to heroin addiction and the most commonly abused substances among 12 and 13-year-olds, with pilfering from family medicine cabinets the number one source for teen abuse. Designed to prevent pilfering, Safe Rx® LPVsTM represent the first improvement to secure packaging for prescription drug dispensing since 1970, when the Poison Prevention Packaging Act established child resistant standards. 

About Safe Rx® LPVsTM
Safe Rx® LPVsTMare physician-developed, child resistant certified locking prescription vials that are tamper-evident and pilfer-resistant.  Designed for use in high volume dispensing, Safe Rx® LPVsTM are engineered for extremely low incremental fill time and easy workflow adaptation.  For more information visit www.safe-rx.com.

 

SOURCE Safe Rx


These press releases may also interest you

at 04:28
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:13
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...

at 03:05
Surge has just closed its second round of funding, raising ?7.5 million. The round was led by Eurazeo with the participation of Kima, Teampact, and MH Innov', as well as the support of historical funds Boutique Venture, HCVC, and 50 Partners Santé....

at 03:00
CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who...



News published on and distributed by: